CLCS · Cell Source, Inc.
$0.74
At close · Sep 3
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“During the three months ended March 31, 2025, we did not generate any revenues, incurred a net loss of approximately $1,482,000 and used cash in operations of approximately $600,000. As of March 31, 2025, we had a working capital deficiency of approximately $20,136,000 and an accumulated deficit of approximately $47,662,000. As of March 31, 2025 and through the date of this filing, notes payable with principal amounts totaling approximately $6,328,000 and $11,116,000, respectively, were past due. We will continue to incur net operating losses to fund operations. These conditions raise substantial doubt about our ability to continue as a going concern for at least one year from the date these financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$60.47M
Shares
67.95M
Options Calculator
Theoretical estimateEstimate what a long-dated option on CLCS could return if you hold it and the stock reaches a target price. Premiums are theoretical Black-Scholes-Merton values — tune the inputs to match your broker, then compare each strike's return against simply holding the shares.
Best strike
—
Highest estimated return
Return at target
—
— annualized
Breakeven
—
Stock price to break even
Hold the stock
—
— annualized, with dividends
Return by strike at your target price
Strike ladder
| Strike | Moneyness | Premium | Breakeven | Value at target | Return | Annualized | Max loss |
|---|
Per share; one contract = 100 shares. Premiums are theoretical Black-Scholes-Merton estimates — real options are American-style and priced off an implied-volatility smile, so use your broker's quote for the actual premium. Not investment advice.
Loading strategy simulator…